MEASURABLE RESIDUAL DISEASE BY MULTIPARAMETRIC FLOW-CYTOMETRY IS A RELIABLE TOOL FOR RISK-STRATIFICATION OF FLT3-MUTATED AML PATIENTS.
R. Palmieri,L. Maurillo,M. I. Del Principe,A. Di Veroli,G. Paterno,E. De Bellis,R. Cerretti,G. De Angelis,B. Mariotti,T. Ottone,M. Divona,S. Lavorgna,M. Irno Consalvo,C. Conti,C. Attrotto,D. Fraboni,M. T. Voso,S. Amadori,F. Lo Coco,W. Arcese,A. Venditti,F. Buccisano HAEMATOLOGICA（2019）
AI 理解论文
溯源树
样例
